Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy

Clinical uncertainty exists regarding which assay should be designated as the standard monitoring coagulation test for intravenous unfractionated heparin (UFH). Several studies have compared the use of activated partial thromboplastin time (aPTT) and antifactor-Xa (anti-Xa) and have come out with va...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Appl Thromb Hemost
Päätekijät: McLaughlin, Kevin, Rimsans, Jessica, Sylvester, Katelyn W., Fanikos, John, Dorfman, David M., Senna, Patricia, Connors, Jean M., Goldhaber, Samuel Z.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829967/
https://ncbi.nlm.nih.gov/pubmed/31530176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619876030
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia